Genome British Columbia - Genome Genomics

image description
You are here:

Sickle cell patients may be the first to be treated with CRISPR

Emily Mullin, MIT Technology Review, discusses how sickle-cell disease may be a good candidate for treatment using the gene editing tool CRISPR because of its genetic origin—a single, well-studied mutation.

Learn More

https://www.technologyreview.com/s/608641/sickle-cell-patients-see-hope-in-crispr/